Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely

BACKGROUND: A subset of patients with chronic myeloid leukemia (CML) can sustain a complete molecular response after discontinuing imatinib mesylate (IM). We focused on microRNAs (miRNAs), with the aim of finding a molecular biomarker to discriminate which patients can safely and successfully discon...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Ohyashiki, Junko H, Ohtsuki, Kazushige, Mizoguchi, Izuru, Yoshimoto, Takayuki, Katagiri, Seiichiro, Umezu, Tomohiro, Ohyashiki, Kazuma
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2014
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4149385/
https://ncbi.nlm.nih.gov/pubmed/25187697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S66812
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍